Home > Products > CD64 & malaria antigen > Recombinant Human Anti-CD64 x Human Anti-malaria antigen Bispecific Antibody (Minibody)

Recombinant Human Anti-CD64 x Human Anti-malaria antigen Bispecific Antibody (Minibody)  (MiniB-H303)

Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (Minibody) is designed to be expressed as the anti-CD64 scFv fused to N-terminus of Knob-CH3 domain and the anti-malaria antigen scFv to the Hole-CH3 domain, or vice versa. The CH3 domains are further stabilized by C-terminal disulfide bonds. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.

Specifications

Targets
CD64 & malaria antigen
Type
Minibody
Species Reactivity
Human
Target 1
CD64
Host Animal 1
Human
Target 2
malaria antigen
Host Animal 2
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Malaria

Targets

Target 1
CD64
Gene ID
UniProt ID
Alternative Names
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
Target 2
malaria antigen
Alternative Names
malaria antigen; parasitic protozoans

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD64 x Human Anti-malaria antigen Bispecific Antibody (Minibody) (MiniB-H303). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "CD64 & malaria antigen"
Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: